{"id":405,"date":"2026-06-28T15:46:05","date_gmt":"2026-06-28T15:46:05","guid":{"rendered":"https:\/\/www.ayahuascanews.org\/?p=405"},"modified":"2026-06-28T15:46:09","modified_gmt":"2026-06-28T15:46:09","slug":"avanza-la-aprobacion-del-lsd-como-medicamento-de-una-sola-dosis-para-la-depresion-y-la-ansiedad","status":"publish","type":"post","link":"https:\/\/www.ayahuascanews.org\/en\/avanza-la-aprobacion-del-lsd-como-medicamento-de-una-sola-dosis-para-la-depresion-y-la-ansiedad\/","title":{"rendered":"APPROVAL OF LSD AS A SINGLE-DOSE MEDICATION FOR DEPRESSION AND ANXIETY MOVES FORWARD"},"content":{"rendered":"

<\/p>\n\n\n\n

On Monday, June 22, 2026, Definium Therapeutics announced positive preliminary results from its Phase 3 study of LSD (DT120) for major depressive disorder (MDD). These are the first Phase 3 results for both the company and LSD.
The data was well received by the markets, and Definium's stock soared following the news. Its market capitalization now exceeds $5.5 billion.<\/p>\n\n\n\n

Meanwhile, in 2024, LSD received \u00abBreakthrough Therapy\u00bb designation for its effectiveness in treating generalized anxiety disorder with a single dose, following the presentation of Mindmed\u2019s positive results for its LSD formulation (MM120). The FDA\u2019s \u00abBreakthrough Therapy\u00bb designation is granted to therapies that are more effective than any other treatment currently available on the market for that condition.<\/p>\n\n\n\n

\"\"<\/figure>","protected":false},"excerpt":{"rendered":"

Este lunes 22 de junio de 2026, Definium Therapeutics anunci\u00f3 resultados preliminares positivos de su estudio de fase 3 sobre LSD (DT120) para el trastorno depresivo mayor (TDM). Se trata de los primeros resultados de fase 3 de la compa\u00f1\u00eda y del LSD.Los datos tuvieron una buena acogida en los mercados, y las acciones de Definium se […]<\/p>","protected":false},"author":2,"featured_media":406,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[20,9,12],"tags":[],"class_list":["post-405","post","type-post","status-publish","format-standard","has-post-thumbnail","category-lsd","category-investigacion","category-psicodelicos"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/www.ayahuascanews.org\/wp-content\/uploads\/2026\/06\/file_00000000d28071f4a71edfe44239faf7.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/posts\/405","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/comments?post=405"}],"version-history":[{"count":1,"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/posts\/405\/revisions"}],"predecessor-version":[{"id":407,"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/posts\/405\/revisions\/407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/media\/406"}],"wp:attachment":[{"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/media?parent=405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/categories?post=405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ayahuascanews.org\/en\/wp-json\/wp\/v2\/tags?post=405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}